Oramed Pharmaceuticals
ORMP
ORMP
61 hedge funds and large institutions have $9.3M invested in Oramed Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
57% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 21
78% less capital invested
Capital invested by funds: $43.2M → $9.3M (-$33.9M)
Holders
61
Holding in Top 10
–
Calls
$314K
Puts
$81K
Top Buyers
| 1 | +$2.96M | |
| 2 | +$1.1M | |
| 3 | +$421K | |
| 4 |
SIGI
Susquehanna International Group (Ireland)
Dublin,
Ireland
|
+$247K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$206K |
Top Sellers
| 1 | -$4.61M | |
| 2 | -$1.23M | |
| 3 | -$707K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$680K |
| 5 |
Man Group
London,
United Kingdom
|
-$665K |